ERNA vs LYB · P/E 0.0, rev $582.0K vs P/E 21, rev $40.30B
Eterna Therapeutics Inc (ERNA) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported LYB revenue for 2024-12-31 was $40.30B. Net income was $1.37B. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the ERNA and LYB stock pages for the full models.
Not investment advice.